Temi della conferenza Running digitally for 2021, the 2nd TCR-based Therapies Summit is the leading industry-focused meeting dedicated to supercharging the expanded TCR repertoire through enhanced target specificity, density and binding affinity for solid tumor indications.
Speakers: Hans-Peter Gerber SVP and CSO 3T Biosciences, Joseph Dukes VP Translational Sciences Enara Bio, Leah Sibener Co-founder, Head of Therapeutic Discovery 3T Bioscience, and more.